| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009495729 |
| P356 | DOI | 10.1186/1742-4690-4-6 |
| P932 | PMC publication ID | 1796897 |
| P698 | PubMed publication ID | 17263871 |
| P5875 | ResearchGate publication ID | 6540415 |
| P50 | author | Georgios Pollakis | Q37369268 |
| William A Paxton | Q91802836 | ||
| P2093 | author name string | Marloes A Naarding | |
| Elly Baan | |||
| P2860 | cites work | Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1 | Q24643931 |
| DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells | Q28138968 | ||
| Diversity of receptors binding HIV on dendritic cell subsets | Q28204326 | ||
| Inhibition of Human Immunodeficiency Virus Infectivity by Chloroquine | Q28323345 | ||
| Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses | Q28616569 | ||
| Antibody neutralization and escape by HIV-1 | Q29547345 | ||
| Rapid and simple method for purification of nucleic acids | Q29615124 | ||
| MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers | Q29617499 | ||
| The anti-HIV-1 activity of chloroquine | Q31884593 | ||
| DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes | Q33250086 | ||
| HIV: The deadly passenger in dendritic cells | Q33597237 | ||
| Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells | Q33806915 | ||
| DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus | Q33840771 | ||
| The role of Langerhans cells in the sexual transmission of HIV. | Q33990719 | ||
| Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. | Q34065317 | ||
| Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes | Q34084515 | ||
| The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. | Q34341843 | ||
| Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120. | Q34983331 | ||
| Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances | Q36205315 | ||
| Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms | Q36352092 | ||
| Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells | Q36365562 | ||
| HIV-1 selection by epidermal dendritic cells during transmission across human skin | Q36400855 | ||
| Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda | Q38881073 | ||
| Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda | Q38885289 | ||
| Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding | Q39685547 | ||
| Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN. | Q39686227 | ||
| Interaction of HIV-1 with dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-expressing cells is influenced by gp120 envelope modifications associated with disease progression | Q40225894 | ||
| Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors. | Q40568140 | ||
| Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity | Q40769773 | ||
| Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine | Q41152773 | ||
| Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine | Q41168935 | ||
| Chloroquine inhibits HIV-1 replication in human peripheral blood lymphocytes | Q41924940 | ||
| Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1. | Q41927429 | ||
| Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. | Q41932765 | ||
| Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells. | Q41937744 | ||
| Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120. | Q43432407 | ||
| Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. | Q44572417 | ||
| Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells | Q45874802 | ||
| The C-type lectin superfamily in the immune system | Q46835986 | ||
| N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization | Q56935643 | ||
| P921 | main subject | chloroquine | Q422438 |
| P304 | page(s) | 6 | |
| P577 | publication date | 2007-01-30 | |
| P1433 | published in | Retrovirology | Q15793508 |
| P1476 | title | Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes. | |
| P478 | volume | 4 |
| Q38291146 | Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action? |
| Q41921243 | Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy |
| Q35172448 | BCA2/Rabring7 targets HIV-1 Gag for lysosomal degradation in a tetherin-independent manner |
| Q38530430 | Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS. |
| Q41940212 | Chloroquine mediated molecular tuning of astrocytes for enhanced permissiveness to HIV infection |
| Q36309457 | Chronic use of chloroquine disrupts the urine concentration mechanism by lowering cAMP levels in the inner medulla |
| Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
| Q39964308 | Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection |
| Q34353780 | Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine |
| Q97527310 | Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study |
| Q34653277 | HIV-associated chronic immune activation |
| Q39048479 | Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy |
| Q37254491 | Immune activation and the role of TLRs and TLR agonists in the pathogenesis of HIV-1 infection in the humanized mouse model |
| Q43973239 | On the use of chloroquine for chikungunya. |
| Q57202110 | Pathobiology of virus glycosylation: implications to disease and prospects for treatment |
| Q57202107 | Protein glycosylation in infectious disease pathobiology and treatment |
| Q21090022 | Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome |
| Q36880738 | Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century |
| Q33713071 | Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation |
| Q39360987 | Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases |
| Q92633499 | The Use of Antimalarial Drugs against Viral Infection |
| Q36446243 | The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel |
| Q37686199 | Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques |
| Q38066127 | Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy |
Search more.